The Therapeutic Innovations Group provides consulting services to drive innovations in drug discovery and early development. We have over 45 years of combined experience, including in-depth knowledge of antibodies, cell therapies, gene therapies, and gene editing.
The Therapeutic Innovations Group has been working with partners focusing on everything from multi-specific antibodies, agonist biologics, iPSC-derived cell therapies and pre-clinical discovery optimization, highlighting our breadth of expertise. Looking forward to connecting with additional partners that we can work with to bring value and success to your discovery efforts.
The Team
-
![An image of The Cultural Center.]()
Michael Naso
Antibodies, cell therapies, gene therapies, nonclinical development, and operational excellence biologic drug discovery through IND.
-
![An image of Greenspacing.]()
Barry Morse
Cell therapies, gene therapies, lead optimization, protein expression, protein biochemistry, vector design. Expertise in Oncology, Immunology, and Infectious Disease Therapeutic areas.
